FDLI’s Winckler to Step Down as President and CEO; Search UnderwayMarch 20, 2014
The Food and Drug Law Institute (“FDLI”) recently announced that President and Chief Executive Officer Susan C. Winckler will step down from that position effective May 23, 2014. Ms Winckler, a pharmacist and attorney, was named to the position in November 2009. She previously served as Chief of Staff at FDA.
“Susan has done a tremendous job leading FDLI over the past 4½ years, and it has been a pleasure working with her. Her presence will be missed,” said Jeffrey N. Gibbs, a Director at Hyman, Phelps & McNamara, P.C. and member of the FDLI Board of Directors and the organization’s General Counsel.
Founded in 1949, FDLI is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction. FDLI is accepting applications for the position of President and CEO (see here). The President and CEO is responsible for developing and managing FDLI’s programs, publications and other services, and is also responsible for membership development, assuring the financial stability of the organization, and leading, motivating and managing FDLI’s staff.